Trial Profile
Photodynamic therapy by laserphyrin and semi-conductor laser in multidisciplinary treatment for unresectable bile duct carcinoma;safety and efficacy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Apr 2019
Price :
$35
*
At a glance
- Drugs Talaporfin (Primary)
- Indications Cholangiocarcinoma
- Focus Adverse reactions
- 05 Apr 2019 Status changed from recruiting to completed.
- 19 May 2017 Status changed from not yet recruiting to recruiting.
- 06 Feb 2017 New trial record